1. Home
  2. QUIK vs VYGR Comparison

QUIK vs VYGR Comparison

Compare QUIK & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo QuickLogic Corporation

QUIK

QuickLogic Corporation

HOLD

Current Price

$21.86

Market Cap

211.8M

Sector

Technology

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.72

Market Cap

203.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QUIK
VYGR
Founded
1988
2013
Country
United States
United States
Employees
51
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
211.8M
203.6M
IPO Year
1997
2015

Fundamental Metrics

Financial Performance
Metric
QUIK
VYGR
Price
$21.86
$3.72
Analyst Decision
Buy
Strong Buy
Analyst Count
1
2
Target Price
$11.00
$16.50
AVG Volume (30 Days)
425.9K
469.9K
Earning Date
05-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$20,112,000.00
$10,135,000.00
Revenue This Year
$75.17
$34.04
Revenue Next Year
$16.04
$7.92
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.80
$2.83
52 Week High
$24.33
$5.55

Technical Indicators

Market Signals
Indicator
QUIK
VYGR
Relative Strength Index (RSI) 56.84 52.36
Support Level $17.30 $3.71
Resistance Level $23.61 $4.29
Average True Range (ATR) 1.88 0.20
MACD -0.25 0.03
Stochastic Oscillator 61.18 69.70

Price Performance

Historical Comparison
QUIK
VYGR

About QUIK QuickLogic Corporation

QuickLogic Corp is a fabless semiconductor company developing programmable logic semiconductor technologies, including embedded Field Programmable Gate Array (eFPGA) intellectual property (IP) and specialized FPGA devices. Its product offerings include the eFPGA IP licensing business and associated professional services, as well as a range of FPGA silicon products, including EOS, ArcticLink III, PolarPro 3, PolarPro II, PolarPro, and Eclipse II products, among others. The company's customers come from various markets, including aerospace and defense, industrial and infrastructure systems, data processing and computing platforms, and certain embedded and edge computing applications. Geographically, it generates maximum revenue from North America and the rest from Asia Pacific and Europe.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

Share on Social Networks: